Get the Stockscreener App
55.01
6.79%
-4.01
After Hours:
55.42
0.41
+0.75%
Phibro Animal Health Corp stock is traded at $55.01, with a volume of 410.62K.
It is down -6.79% in the last 24 hours and up +11.20% over the past month.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
See More
Previous Close:
$59.02
Open:
$58.13
24h Volume:
410.62K
Relative Volume:
1.44
Market Cap:
$2.23B
Revenue:
$1.46B
Net Income/Loss:
$92.09M
P/E Ratio:
24.39
EPS:
2.2555
Net Cash Flow:
$47.29M
1W Performance:
-6.22%
1M Performance:
+11.20%
6M Performance:
+40.55%
1Y Performance:
+227.25%
1-Day Range:
$53.71
$58.83
1-Week Range:
$53.71
$60.08
52-Week Range:
$16.16
$60.08
Phibro Animal Health Corp Stock (PAHC) Company Profile
Name
Phibro Animal Health Corp
Sector
Phone
201-329-7300
Address
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
55.01 | 2.39B | 1.46B | 92.09M | 47.29M | 2.2555 |
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 56.39B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
120.76 | 50.93B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.66 | 43.19B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.61 | 36.99B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
577.58 | 25.36B | 3.18B | 1.33B | 1.04B | 27.90 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-16-25 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Sep-10-24 | Initiated | JP Morgan | Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Underperform |
| Dec-21-22 | Initiated | ROTH Capital | Buy |
| Jul-25-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-10-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Nov-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-07-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Aug-06-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-06-20 | Downgrade | Gabelli & Co | Buy → Hold |
| Jan-28-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Sep-05-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Aug-29-19 | Reiterated | BofA/Merrill | Underperform |
| Jun-11-19 | Initiated | Barclays | Underweight |
| May-23-19 | Initiated | Guggenheim | Neutral |
| May-09-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Aug-23-17 | Resumed | BofA/Merrill | Underperform |
| Jun-02-17 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-15-16 | Initiated | Piper Jaffray | Overweight |
| Nov-11-16 | Downgrade | Macquarie | Neutral → Underperform |
| Nov-10-16 | Downgrade | Gabelli & Co | Buy → Hold |
| Apr-11-16 | Reiterated | Guggenheim | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Jan-15-16 | Downgrade | Barclays | Overweight → Underweight |
| Sep-30-15 | Initiated | Gabelli & Co | Buy |
| Apr-24-15 | Reiterated | Barclays | Overweight |
| Apr-21-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-06-14 | Initiated | Barclays | Overweight |
View All
Phibro Animal Health Corp Stock (PAHC) Latest News
PAHC Initiates Coverage by Citigroup -- Price Target Announced a - GuruFocus
Phibro director Joyce J. Lee to resign effective April 15, 2026 - TradingView — Track All Markets
Board member Joyce Lee to leave Phibro Animal Health (NASDAQ: PAHC) - Stock Titan
Phibro Animal Health Corp. Hits New 52-Week High of $59.67 - Markets Mojo
Phibro Animal Health Corp. Opens with 5.07% Gain, Outperforming S&P 500 - Markets Mojo
PAHC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Phibro Animal Health Corporatio (PAHC) Stock forecasts - Yahoo Finance UK
Phibro Animal Health stock hits all-time high at 59.08 USD - Investing.com
FMR LLC reports 2.17M shares in PHIBRO Animal Health (PAHC) — 10.5% stake - Stock Titan
Why Teladoc Deserves Patience Now: Too Early to Buy, Too Risky to Sell - TradingView — Track All Markets
Did Strong Vaccine and International Results Just Shift Phibro Animal Health's (PAHC) Investment Narrative? - Yahoo Finance
Zacks Investment Ideas feature highlights Phibro, Deluxe, Remitly and BrightSpring - Yahoo Finance
Phibro Animal Health Corp-A (NASDAQ:PAHC) Passes Minervini's High-Growth Momentum Screen - ChartMill
BFI Co. sells $757k in Phibro Animal Health (PAHC) stock By Investing.com - Investing.com South Africa
BFI Co. sells $757k in Phibro Animal Health (PAHC) stock - Investing.com
Bendheim-linked BFI Co. LLC (PAHC) sells 14,080 shares under 10b5-1 - Stock Titan
4 Small Cap Stocks with Outstanding Fundamentals and Momentum - TradingView — Track All Markets
Evaluating Acadia Healthcare's Outlook: Hold for Now or Fold? - TradingView — Track All Markets
Momentum Shift: How do insiders feel about Phibro Animal Health CorporationWeekly Trade Report & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Sentiment Recap: What is the long term forecast for Phibro Animal Health Corporation stockTrade Exit Summary & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Phibro Animal Health Stock Up 152.3% in a Year: What's Driving It? - Yahoo Finance
Phibro Animal Health Corp. Hits New 52-Week High of $57.62 - Markets Mojo
Vanguard disaggregates holdings; reports 0 PAHC shares (PAHC) - Stock Titan
BFI Co. sells Phibro Animal Health (PAHC) shares for $1.16 million - Investing.com
Phibro Animal Health (PAHC) insider entity BFI Co. sells 21,120 shares - Stock Titan
Is Phibro Animal Health’s (PAHC) Efficiency Surge Quietly Rewriting Its Competitive Position in Animal Health? - simplywall.st
Reasons Behind Holding Humana Shares: What Investors Need to Know - TradingView — Track All Markets
Phibro Animal Health stock hits all-time high at 56.86 USD - Investing.com
TerrAscend (OTCMKTS:TSNDF) and Phibro Animal Health (NASDAQ:PAHC) Head to Head Analysis - Defense World
Insider Selling: Phibro Animal Health (NASDAQ:PAHC) CEO Sells $272,764.80 in Stock - Defense World
Is It Too Late To Consider Phibro Animal Health (PAHC) After Its 143% One Year Surge? - Yahoo Finance
BFI Co sells Phibro Animal Health (PAHC) stock worth $1.19 million By Investing.com - Investing.com South Africa
BFI Co sells Phibro Animal Health (PAHC) stock worth $1.19 million - Investing.com Australia
Insider Selling: Phibro Animal Health (NASDAQ:PAHC) CEO Sells 10,560 Shares of Stock - MarketBeat
Phibro Animal Health (PAHC) CEO-linked BFI Co. sells 22,880 shares in Rule 10b5-1 trades - Stock Titan
Phibro Animal Health says Daniel Bendheim to assume CEO role in July - MSN
Volatility Watch: Is Phibro Animal Health Corporation gaining market shareOil Prices & Weekly Setup with ROI Potential - baoquankhu1.vn
Phibro Animal Health (PAHC) director Bendheim sells $258,244 in shares By Investing.com - Investing.com India
Phibro Animal Health (PAHC) director Bendheim sells $258,244 in shares - Investing.com
BrightSpring Health Services, Collegium Pharmaceutical, and Phibro Animal Health Shares Are Soaring, What You Need To Know - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) CEO Jack Bendheim Sells 5,280 Shares - MarketBeat
BFI Co. tied to Phibro Animal Health (PAHC) converts and sells shares - Stock Titan
A Look At Phibro Animal Health (PAHC) Valuation After Recent Share Price Gains - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Upgraded at Zacks Research - Defense World
Multiple resale transactions by affiliate reported for Phibro Animal Health (PAHC) - Stock Titan
Zacks Research Upgrades Phibro Animal Health (NASDAQ:PAHC) to Strong-Buy - MarketBeat
Is PAHC Stock a Solid Investment Opportunity Right Now? - Yahoo Finance
Looking for earnings beat? Buy these 4 top-ranked stocks - MSN
EPS Watch: Will Phibro Animal Health Corporation benefit from AI trends2026 Momentum Check & Verified Swing Trading Watchlists - baoquankhu1.vn
Is Community Health Systems Attractive Despite Its Heavy Debt Load? - TradingView
Is It Too Late To Consider Phibro Animal Health (PAHC) After 1-Year Share Price Surge? - simplywall.st
Phibro Animal Health Corp Stock (PAHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):